GLP-1 receptor agonists (GLP-1RAs) were initially approved for diabetes treatment (e.g., Ozempic®) but have revolutionized weight management ...

FDA ends GLP-1 drug shortage. Concerns over safety, counterfeit drugs, and high cost of brand-name versions persist; ...

Weight loss drugs like Ozempic deliver more health benefits than expected.

The Outsourcing Facilities Association is appealing a ruling that rejected their request for an injunction against the FDA’s ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...

Discover how peptides are transforming medical treatments, metabolic conditions and more with fewer side effects than ...

Weight-inclusive health care is the provision of equitable care without perpetuating weight stigma among patients of all body ...

The federal government has spent $6.2 billion on research and development for weight-loss drugs. Now, thanks to Big Pharma ...

He's a transplant surgeon and obesity medicine specialist at NYU Langone Health in New York City. Glucagon-like peptide-1 (GLP-1) drugs mimic the GLP-1 hormone, which helps control insulin and blood ...

GLP-1 receptor agonists show promise in treating alcohol addiction by modulating reward pathways and reducing cravings, offering a novel therapeutic approach.

A Central Illinois cardiologist breaks down the potential benefits of GLP-1 medications on heart health. It was one of the ...